Apraclonidine
Back to searchMolecule Structure
Scientific Name
Apraclonidine
Description of the Drug
Apraclonidine is an alpha adrenergic agonist used to treat raised intraocular pressure.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00964
http://www.drugbank.ca/drugs/DB00964
Brand Name(s)
Iopidine
Company Owner(s)
Imprimis Pharmaceuticals Usa Llc, Akorn Operating Co Llc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Adrenergic receptor alpha-2 | PROTEIN FAMILY | AGONIST | CHEMBL2095158 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL34127 | ||
| PharmGKB | PA164748866 | ||
| Human Metabolome Database | HMDB0015099 | ||
| DrugBank | DB00964 | ||
| PubChem: Thomson Pharma | 16363243 | 14749680 | |
| PubChem | 2216 | ||
| Nikkaji | J247.956G | ||
| BindingDB | 50021812 | 81926 | |
| EPA CompTox Dashboard | DTXSID1048415 | ||
| DrugCentral | 229 | ||
| Guide to Pharmacology | 7117 | ||
| rxnorm | APRACLONIDINE | IOPIDINE | APRACLONIDINE HYDROCHLORIDE |
| KEGG Ligand | C07668 | ||
| ChEBI | 2788 | ||
| ZINC | ZINC000000020231 |
